Harpoon, Aligos announce PIPEs; NAYA’s all-stock deal; Invea to go public

Har­poon’s $150M PIPE: Har­poon Ther­a­peu­tics an­nounced a pri­vate place­ment that is ex­pect­ed to raise a to­tal of $150 mil­lion a month af­ter Ab­b­Vie opt­ed out of an ex­clu­sive op­tion for its BC­MA-tar­get­ing T cell en­gager in mul­ti­ple myelo­ma. The biotech did not dis­close the lead in­vestor, though it not­ed that its in­vestors in­clude Soleus Cap­i­tal, Com­modore Cap­i­tal and New Leaf Ven­ture Part­ners, among oth­ers. Its stock $HARP was down about 8% on Mon­day morn­ing af­ter the PIPE was an­nounced.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.